云南高校图书馆联盟文献共享服务平台- HEPATOCELLULAR

HEPATOCELLULAR: 作品数：1273被引量：7979H指数：37; 导出分析报告; 相关领域：医药卫生更多>>; 相关作者：张福君张亮吴沛宏顾仰葵赵明更多>>; 相关机构：第二军医大学中山大学中国人民解放军总医院广州军区广州总医院更多>>; 相关期刊：更多>>; 相关基金：国家自然科学基金国家重点基础研究发展计划中国博士后科学基金广东省自然科学基金更多>>

Systemic treatment for hepatocellular carcinoma beyond milan criteria on the waitlist:is it time for a neoadjuvant therapy?: 《Hepatoma Research》2023年第1期688-692,共5页Bianca Magro Michela Triolo Ciro Celsa Duilio Pagano Giuseppe Cabibbo Calogero Cammà Stefano Fagiuoli Salvatore Gruttadauria; Dear Editor,Liver transplantation(LT)is the best option for the treatment of both cirrhosis and hepatocellular carcinoma(HCC),providing the best long-term outcomes,particularly for patients within the Milan criteria[1...; 关键词：HEPATOCELLULAR TREATMENT LIVER

Combined hepatocellular-cholangiocarcinoma:morpho-molecular updates and considerations: 《Hepatoma Research》2023年第1期414-425,共12页Naghia Ahmed Francesca Falcinelli Margherita Rimini Valentina Burgio Andrea Casadei-Gardini Luca Aldrighetti Francesca Ratti Federica Pedica; Combined Hepatocellular-Cholangiocarcinoma is a heterogenous primary malignant epithelial tumor of the liver with variable morphological and immunophenotypical features.Although the biology of this tumor has been desc...; 关键词：Combined hepatocellular-cholangiocarcinoma WHO classification IMMUNOHISTOCHEMISTRY molecular analyses

Current landscape and future directions for systemic treatments of hepatocellular carcinoma: 《Hepatoma Research》2023年第1期1-5,共5页Leonardo G.Fonseca Flair J.Carrilho; Systemic treatment is the optimal approach for patients with advanced or intermediate-stage hepatocellular carcinoma(HCC)with contraindications or refractoriness to locoregional treatments[1].The aim of systemic treat...; 关键词：HEPATOCELLULAR TREATMENT CLINICAL

Erratum:Long-term survival of occult hepatitis B associated hepatocellular carcinoma following surgery and antiviral therapy: 《Hepatoma Research》2022年第1期380-380,共1页Tina Boortalary Ernest Rosato Christopher Roth Xiangdong David Ren Selena YLin Hie-Won Hann; This is an Erratum of the publsihed paper:Long-term survival of occult hepatitis B associated hepatocellular carcinoma following surgery and antiviral therapy.The ethical approval and consent to participation informat...; 关键词：SURGERY HEPATOCELLULAR HEPATITIS

Hepatitis B virus(HBV)and hepatocellular carcinoma(HCC)in sub-Saharan Africa:no room for complacency: 《Hepatoma Research》2022年第1期207-211,共5页Philippa C.Matthews Anna Kramvis; funding from the Wellcome Trust(Grant ref 110110/Z/15/Z);the Francis Crick Institute,London.; The increasing incidence and mortality of hepatocellular carcinoma(HCC)driven by hepatitis B virus(HBV)infection is a global public health concern[1].Despite World Health Organization(WHO)targets for the elimination o...; 关键词：HEPATOCELLULAR MORTALITY (HBV)

CALL FOR PAPERS: 《Hepatoma Research》2019年第9期前插1-前插1,后插1-后插6,共7页; Guest Editor:Professor Jose J.G.Marin Carlos III National Institute of Health,Spain Submission begins:November 1,2016 Possible submission deadline:May 1,2017 Dear Friends and Colleagues,Greetings!I hope that you will ...; 关键词：submit HEPATOCELLULAR SUBMISSION

The role of APOBEC3B in the development of hepatocellular carcinoma should be investigated with the consideration of hepatitis B virus evolution: 《Hepatoma Research》2019年第8期7-10,共4页Wen-Bin Liu Guang-Wen Cao; This work was supported by grant(2015CB554006)from the National Key Basic Research Program of China(GC); The chronic infection of hepatitis B virus(HBV)is the major cause of hepatocellular carcinoma(HCC)globally[1].In Eastern China,chronic HBV infection contributes to 87.5%of HCC whereas chronic hepatitis C virus(HCV)inf...; 关键词：INFECTION HEPATOCELLULAR HEPATITIS

Efficacy and safety of immune checkpoint therapy in hepatocellular carcinoma: meta-analysis: 《Hepatoma Research》2019年第6期7-15,共9页Weina Tang Long-Teng Ma Yang Deng Wei Wang Hong-Wei Zhang; This work was supported by National Key Basic Research Program of China(No.2015CB554000).; Aim:Immune checkpoint inhibitors(ICIs)are proven to be an effective way to treat the disease of hematologic malignancies.But there is still plenty of uncertainty about the effectiveness of ICIs on hepatocellular carci...; 关键词：HEPATOCELLULAR immune-checkpoint inhibitor CLAT-4 PD1/PD-L1

Controversies of hepatectomy and adjuvant therapy for hepatocellular carcinoma: moving forward被引量：1: 《Hepatoma Research》2019年第6期1-6,共6页Jian-Hong Zhong Bang-De Xiang; This work was supported by the National Major Special Science and Technology Project(2017ZX10203207);Graduate Course Construction Project of Guangxi Medical University(YJSA2017014);the Foundation Ability Enhancement Project for Young Teachers in Guangxi Universities(2018KY0122),the Guangxi Natural Science Foundation(2018GXNSFBA138018),and Guangxi BaGui Young Scholars.; Due to the prevelence of hepatitis B virus(HBV)and hepatitis C virus(HCV),occurrence of hepatocellular carcinoma(HCC)is increasing in many countries/regions,including China[1].; 关键词：HEPATOCELLULAR ADJUVANT HEPATITIS

Telomerase reverse transcriptase promoter mutations in hepatocellular carcinogenesis: 《Hepatoma Research》2019年第3期8-19,共12页Zi-Xian Ma Chun-Mei Yang Meng-Ge Li Hong Tu; This work was supported by grants from the National Natural Science Foundation of China(81572312);Chinese National Key Project Specialized for Infectious Diseases(2017ZX10201201-008-003);National Key Research and Development Program of China(2017YFC0908103);Chinese State Key Laboratory of Oncogenes and Related Genes(91-14-16,91-15-06).; Through several studies exploiting next-generation sequencing,we are obtaining a clearer picture of the complex genetic and molecular landscape of hepatocellular carcinoma(HCC).Consistent with the findings of other ca...; 关键词：Hepatocellular carcinoma telomerase reverse transcriptase mutation hepatitis B virus

HEPATOCELLULAR